prostate cells

[Scientific Reports] The authors revealed the important role of insulin gene enhancer-binding protein 1 (ISL1) in androgen receptor (AR)-dependent prostate cancer cell growth; ISL1 knockdown reduced the AR activity and cell growth.

[Cell & Bioscience] The authors revealed the potential mechanisms of which GV1001-stimulated Gαs-cAMP signaling pathway reduced the migration and metastasis of prostate cancer cells.

[Molecular Cancer therapeutics] Scientists suggested that DNA methylation pathway is deregulated after enzalutamide resistance onset and that targeting DNA methyltransferases restored the sensitivity to enzalutamide in prostate cancer cells.

[Journal of Materials Chemistry B] The authors observed that prostate cancer cells and breast cancer cells cultured with nanodiamonds showed morphological changes and altered gene and protein expression.

[Acta Biochimica et Biophysica Sinica] Researchers evaluated the potential role of epicatechin gallate in prostate cancer cells and found that epicatechin gallate downregulated the expression of acetyl-CoA carboxylase, ATP citrate lyase, and fatty acid synthase in prostate cancer cells.

[Cancer Research] Investigators identified a long non-coding RNA, NXTAR, that was located convergent with the androgen receptor gene and was repressed in human prostate tumors and cell lines.